We also attempted to determine the effect of PKCε knockdown on drug sensitivity in AML cell lines and in primary AML patient-derived lines, however none of the cells in these panels demonstrated overexpression of PKCε making the experiments difficult to interpret. The gene discussed is PRKCE; the disease is acute myeloid leukemia.